在中度至重度斑块性牛皮的儿科患者中使用secuquinumab的疗效:一项随机化研究
Yuping Zhang1,2, Xiji Lu3, Ying Zhou1
1Department of dermatology, Zhongshan City People's Hospital, Zhongshan, China.
Medicine
|November 15, 2025
概括
与传统疗法相比,secukinumab有效治疗中度至严重的儿科牛皮,显著改善皮肤清除和生活质量. 这种干白素-17A抑制剂对中国的年轻患者来说非常有前途.
科学领域:
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
- 儿科医学 儿科医学
背景情况:
- 一种IL-17A抑制剂Secukinumab在欧盟和美国已被批准用于治疗儿科牛皮,但不是中国.
- 牛皮会影响儿童,影响他们的生活质量.
- 对儿科牛皮的新生物疗法进行评估至关重要.
研究的目的:
- 评估中国儿科患者中度至重度斑块性牛皮的secukinumab的临床疗效和安全性.
- 为了比较secukinumab与传统的非生物疗法.
主要方法:
- 一项随机的单中心研究,涉及33名儿科患者 (6-17岁).
- 治疗组包括sequinumab和传统的非生物疗法.
- 主要结局:BSA,PASI 75/90/100,IGA 0/1,DLQI,以及不良事件.
主要成果:
- 与传统治疗相比,secukinumab显著降低了BSA和PASI得分.
- 较高的IGA 0/1,DLQI改善率和PASI 90响应率与secukinumab一起观察到.
- 在150mg和300mgsecukinumab之间没有显著的剂量依赖差异.
结论:
- 塞库金纽马布在中国儿科患者中表现出治疗效果和安全性,这些患者患有中度至重度斑块性牛皮.
- 这些发现支持sequukinumab作为这种人群的潜在治疗选择.
- 进一步的研究可能会探索长期结果和比较有效性.
相关概念视频
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
197
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
197
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
249
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
249
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
182
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
182
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
234
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
234